US Stock Market Move | AI will be used to develop weight loss drugs, and Novo Nordisk A/S Sponsored ADR Class B (NVO.US) has increased by nearly 2% against the trend.

10/01/2025

GMT Eight

On Friday, Novo Nordisk A/S Sponsored ADR Class B (NVO.US) rose nearly 2% against the market trend, closing at $86.77 USD. In terms of news, the company and the U.S. technology company Valo Health recently announced their agreement to expand the scope of their collaboration to develop up to 11 drugs by 2023, utilizing human data and artificial intelligence (AI) to develop up to 20 new therapies for obesity, type 2 diabetes, and cardiovascular diseases.

SUN.KING TECH (00580) announced a profit increase, with the expected annual net profit attributable to the parent company's owners to be approximately 1 billion yuan, a year-on-year increase of approximately 200%.

US Stock Market Move | Large tech stocks are falling, Netflix (NFLX.US) is down more than 4%.

Contact: contact@gmteight.com

US Stock Market Move | AI will be used to develop weight loss drugs, and Novo Nordisk A/S Sponsored ADR Class B (NVO.US) has increased by nearly 2% against the trend.

RECOMMEND

US Stock Market Move | The United States plans to tighten regulations on the export of AI chips, causing AMD Semiconductor (AMD.US) to fall nearly 5%.

US Stock Market Move | Lowering the 2025 fiscal year performance guidance, the constellation brand (STZ.US) plummeted more than 10%.

US Stock Market Move | Los Angeles fire causes widespread damage, insurance sector plunges.